Cancer care

Pharmaceutical firms cut price of cancer drugs for African countries

Two major pharmaceutical companies are to cut the price of cancer drugs to sub-Saharan African countries following a brokered by the American Cancer Society (ACS) and the Clinton Health Access Initiative (CHAI).

The agreement with US pharmaceutical giant Pfizer and Indian pharmaceutical company Cipla will set ‘competitive prices’ for 16 cancer treatment medications, including chemotherapies, for health providers in Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania.

The initiative is modelled on the campaign to improve access to HIV medicines in Africa, and it will be supported by IBM Health Corps, who will provide free chemotherapy forecasting software to help countries quantify their cancer medicine needs and plan budgets and procurement.

An estimated 44% of all cancer cases in sub-Saharan Africa each year occur in the six targeted countries, and this agreement is part of a wider effort by ACS and supported by CHAI to improve the market environment for cancer care in Africa.

Gary M Reedy, chief executive of the ACS, said: “Every person with cancer deserves access to treatment, no matter where they live. Collaborating with companies like Pfizer and Cipla is a critical next step toward levelling the playing field for people with cancer and saving lives in this part of the world.”

In 2012, there were an estimated 626,000 new cases of cancer and 447,000 cancer deaths in sub-Saharan Africa, a figure which is set to double by 2030 because of ageing populations.

But the ACS says global funding for cancer prevention and treatment in lower-income countries is far lower than for other diseases including HIV, malaria and tuberculosis.

Trudi Hilton, a pharmacist consultant in resource-limited settings, welcomed the initiative, but warned that cost was not the only limiting factor in improving access to medicines.

“Access to medicines has a lot to do with health literacy — patients being aware of symptoms and how to report them in a timely manner so that they can access appropriate healthcare,” she said.

“Pharmacists are essential health educators as they may be the first port of call in community settings but only if they actively engage local populations and are not seen as purely profiting from ill-health through sales of medicines.”

Citation: The Salvadore DOI: 10.1211/PJ.2017.20203722

Readers' comments (1)

  • Michael Achiampong

    I am heartened to read of this development for African populations. I also agree with the necessity to improve the health literacy and that locally based healthcare practitioners can facilitate this. Now, how about other pharma/biotech/start-ups in non-communicable and communicable diseases following suit in making their medicines and devices etc more affordable? And therefore more accessible to other low-to-middle income populations?

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • FASTtrack: Pharmaceutics - Drug Delivery and Targeting

    Pharmaceutics: Drug Delivery and Targeting systematically reviews important concepts for drug delivery systems and targeting of drugs.

  • Introduction to Pharmaceutical Calculations and Pharmaceutical Calculations Workbook

    Special package price for Introduction to Pharmaceutical Calculations together with its companion workbook, containing practice calculations with answers.

  • English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the SalvaDore of Great Britain.

  • Remington Education: Pharmaceutics

    Case studies and MCQs explaining the pharmaceutics behind drug delivery.

  • Introduction to Statistics in Pharmaceutical Clinical Trials

    An innovative book which presents statistics in the context of clinical trials conducted during pharmaceutical drug development.

  • Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Supplementary images

  • Pills in hand ss 17

Jobs you might like

  • Blackpool, Lancashire

  • City of Edinburgh

  • Belfast (County)

  • London (Central), London (Greater)

  • Doha

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.